Skip to content
10-Q

Quarterly Report

BioCorRx Inc. BICX

0001477932-24-007148

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 14, 2024 12.75M sh
Stockholders Equity Q3 2024 · Sep 30, 2024 −$11.83M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$9.82M
Current Liabilities Q3 2024 · Sep 30, 2024 $8.22M
Current Liabilities Q3 2024 · Dec 31, 2023 $6.43M
Total Liabilities Q3 2024 · Sep 30, 2024 $12.65M
Total Liabilities Q3 2024 · Dec 31, 2023 $10.34M
Current Assets Q3 2024 · Sep 30, 2024 $353.1K
Current Assets Q3 2024 · Dec 31, 2023 $187.12K
Total Assets Q3 2024 · Sep 30, 2024 $643.57K
Total Assets Q3 2024 · Dec 31, 2023 $388.89K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $0
Cost Of Revenue Q3 2024 · Sep 30, 2024 $1.67K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $3.88K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $22.93K
Net Income Q3 2024 · Jun 30, 2024 −$1.23M
Net Income Q3 2024 · Mar 31, 2024 −$1.24M
Net Income Q3 2024 · Sep 30, 2023 −$867.35K
Net Income Q3 2024 · Jun 30, 2023 −$923.55K
Net Income Q3 2024 · Mar 31, 2023 −$1.01M
Shares Diluted Q3 2024 · Sep 30, 2023 2.28M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$1.32M
Sga Expense Q3 2024 · Sep 30, 2023 $674.46K
Sga Expense Q3 2024 · Sep 30, 2023 $2.18M
Rd Expense Q3 2024 · Sep 30, 2023 $286.96K
Rd Expense Q3 2024 · Sep 30, 2023 $762.77K
Operating Income Q3 2024 · Sep 30, 2023 −$961.87K
Operating Income Q3 2024 · Sep 30, 2023 −$2.97M
Revenue Q3 2024 · Sep 30, 2023 $10.15K
Revenue Q3 2024 · Sep 30, 2023 $70.22K